Roivant (NASDAQ: ROIV) CIO sells option shares near $37
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) reported that President & CIO Mayukh Sukhatme exercised stock options and sold the resulting common shares over three days. He exercised options covering 335,174 Common Shares at an exercise price of $3.85 per share, fully vested per the award footnote, and received an equal number of Common Shares. On August 19, 20 and 21, 2026, he sold 172,899, 17,519 and 144,756 Common Shares, respectively, at weighted average prices of $37.17, $37.30 and $36.48 per share in multiple transactions within the stated price ranges.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 335,174 shares ($11.07M approx. pre-tax spread)
Exercise and Sale
9 txns
Insider
Sukhatme Mayukh
Role
President & CIO
Sold
335,174 shs ($12.36M)
Approx. gross sale proceeds
$12.36M
Approx. exercise cost
$1.29M
Approx. pre-tax spread
$11.07M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F4 | 144,756 | $0.00 | $0.00 |
| Exercise | Common Shares | 144,756 | $3.85 | $557K |
| Sale | Common Shares F3 | 144,756 | $36.48 | $5.28M |
| Exercise | Stock Option (Right to Buy) F4 | 17,519 | $0.00 | $0.00 |
| Exercise | Common Shares | 17,519 | $3.85 | $67K |
| Sale | Common Shares F2 | 17,519 | $37.30 | $653K |
| Exercise | Stock Option (Right to Buy) F4 | 172,899 | $0.00 | $0.00 |
| Exercise | Common Shares | 172,899 | $3.85 | $666K |
| Sale | Common Shares F1 | 172,899 | $37.17 | $6.43M |
Holdings After Transaction:
Stock Option (Right to Buy) — 13,224,363 shares (Direct);
Common Shares — 18,630,739 shares (Direct)
Footnotes (4)
- F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $37.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.20 to $37.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $37.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F4. Award of stock options to purchase Common Shares that is fully vested.
Key Figures
Options exercised: 335,174 shares
Shares sold: 335,174 shares
Option exercise price: $3.85 per share
+4 more
7 metrics
Options exercised
335,174 shares
Total Common Shares underlying Stock Options (Right to Buy) exercised on August 19–21, 2026
Shares sold
335,174 shares
Total Common Shares sold in open-market or private transactions on August 19–21, 2026
Option exercise price
$3.85 per share
Conversion or exercise price for Stock Options (Right to Buy) expiring April 19, 2032
Weighted average sale price 2026-08-19
$37.17 per share
Common Shares sold in multiple transactions at prices ranging from $36.80 to $37.42
Weighted average sale price 2026-08-20
$37.30 per share
Common Shares sold in multiple transactions at prices ranging from $37.20 to $37.51
Weighted average sale price 2026-08-21
$36.48 per share
Common Shares sold in multiple transactions at prices ranging from $36.25 to $37.16
Option expiration date
April 19, 2032
Expiration date for the Stock Option (Right to Buy) awards exercised
Key Terms
Stock Option (Right to Buy), weighted average price, Exercise or conversion of derivative security, fully vested
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" with underlying Common Shares"
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
fully vested financial
"Award of stock options to purchase Common Shares that is fully vested."
FAQ
What insider transactions did ROIV executive Mayukh Sukhatme report on this Form 4?
Mayukh Sukhatme reported exercising stock options for 335,174 Common Shares at $3.85 per share and selling an equal number of 335,174 Common Shares in open-market transactions on August 19–21, 2026, at weighted average prices around $37 per share.
What were the key terms of the stock options exercised by the ROIV executive?
The options were described as an award of stock options to purchase Common Shares that is fully vested, with an exercise price of $3.85 per share and an expiration date of April 19, 2032. In total, options for 335,174 shares were exercised.
Were Mayukh Sukhatme’s Form 4 transactions in ROIV under a Rule 10b5-1 trading plan?
The Form 4’s Rule 10b5-1 checkbox is not marked as affirming that the reported transactions were made pursuant to a Rule 10b5-1 trading plan, and the footnotes do not state that a trading plan applied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
